COMMUNIQUÉS West-GlobeNewswire

Effective May 2, 2025, Interpace Diagnostics® Will No Longer Accept Specimens for PancraGEN®, a Molecular Diagnostic Test That Assesses Pancreatic Cyst Cancer Risk
24/04/2025
Interpace Expects to Remain Profitable as a Thyroid-focused Business PARSIPPANY, NJ, April 24, 2025 (GLOBE NEWSWIRE) -- Interpace Diagnostics ® , a subsidiary of Interpace Biosciences ® , (“Interpace” or the “Company [...]
Progyny, Inc. Announces Details for Its First Quarter 2025 Results Report
24/04/2025
NEW YORK, April 24, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women’s health and family building, will report its financial results for the quarterly period ended March 31, 2025, after [...]
May is Brain Cancer Awareness Month: Illuminate the Fight Against One of the Most Lethal Cancers
24/04/2025
TORONTO, April 24, 2025 (GLOBE NEWSWIRE) -- This May, Brain Cancer Canada (BCC) and communities across the country prepare to rally for Brain Cancer Awareness Month. Dedicated to supporting those impacted by brain [...]
Tenaya Therapeutics Presents Interim Data from RIDGE™ Natural History and Seroprevalence Study of Adults with PKP2-associated ARVC at Heart Rhythm 2025
24/04/2025
RIDGE is Largest Natural History Study Conducted with More Than 175 Participants Enrolled to Date with Arrhythmogenic Right Ventricular Cardiomyopathy Due to Mutations in the PKP2 Gene Patients Experience High Burden of [...]
Faraday Pharmaceuticals to Host Satellite Symposium at SCAI 2025 on Exploring New Frontiers in Reducing Ischemia-Reperfusion Injury
24/04/2025
SEATTLE, April 24, 2025 (GLOBE NEWSWIRE) -- Faraday Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on preventing heart failure by reducing myocardial damage in acute ST-elevation myocardial [...]
Imprivata Names Joel Burleson-Davis as Chief Technology Officer
24/04/2025
Experienced leader and technology visionary to accelerate innovation at Imprivata to help customers solve pressing access management, security, and workflow challenges WALTHAM, Mass., April 24, 2025 (GLOBE NEWSWIRE) -- [...]
Clariane I 2025 first-quarter revenue
24/04/2025
Press release Revenue for the three months to 31 March 2025 rose by 4.8% on an organic basis, which equates to a 5.5% increase on a comparable number of days. All businesses and regions contributed to revenue growth , [...]
Clariane I Chiffre d’affaires au 31 mars 2025
24/04/2025
Communiqué de presse Le chiffre d’affaires au 31 mars 2025 progresse en base organique de +4,8%, ce qui correspond à une croissance de + 5,5% à nombre de jours comparable L’ensemble des activités et des régions [...]
Best Kratom for Energy: Top Strains Recommended by Happy Go Leafy
24/04/2025
Searching for the best kratom for energy strains? Go to Happy Go Leafy’s official website and find the best options available. Enjoy premium pricing & discounts! Miami, Florida, April 24, 2025 (GLOBE NEWSWIRE) -- [...]
Vivoryon Therapeutics N.V. Signs Financing Agreement for up to EUR 15 Million
24/04/2025
Vivoryon Therapeutics N.V. Signs Financing Agreement for up to EUR 15 Million Halle (Saale) / Munich, Germany, April 24, 2025 – Vivoryon Therapeutics N.V. (Euronext Amsterdam: VVY; NL00150002Q7) (“ Vivoryon ” or the “ [...]
SAFE Group signe un accord de distribution au Venezuela et annonce le succès de la première chirurgie
24/04/2025
SAFE Group signe un accord de distribution au Venezuela et annonce le succès de la première chirurgie Fleurieux-sur-l’Arbresle - France - le 24 avril 2025 à 18h . Safe SA (la « Société ») est fière d'annoncer la [...]
Guerbet: Q1 2025 revenue
24/04/2025
Q1 2025 revenue Quarterly activity Revenue: €180.1m, down 7.1% at CER 1 and on a like-for-like basis 2 As expected, a first quarter marked by a persistent impact on France and a penalizing base effect Declining momentum [...]
GUERBET: Chiffre d’affaires du 1er trimestre 2025
24/04/2025
Chiffre d’affaires du 1 er trimestre 2025 Activité trimestrielle Chiffre d’affaires : 180,1 M€, en repli de 7,1% à TCC 1 et périmètre comparable 2 Comme anticipé, un premier trimestre marqué par un impact France [...]
Koelis annonce un partenariat avec Bot Image™ lors du congrès de l’AUA 2025
24/04/2025
Une nouvelle technologie d’IA pour améliorer la précision des biopsies de la prostate et l’efficacité des procédures GRENOBLE, France et PRINCETON, New Jersey, 24 avr. 2025 (GLOBE NEWSWIRE) -- Koelis, SAS (« Koelis » ou [...]
PCI Biotech Holding ASA: Annual Report 2024
24/04/2025
Oslo, Norway, April 24, 2025 The Board of Directors of PCI Biotech Holding ASA has approved the Annual Report 2024. Please find the report attached, as well as the report according to the European Single Electronic [...]
Best Dental Implants in Seattle Done by Dr. Javadi
24/04/2025
Dr. Javadi Successfully Places Dental Implants Using CT Guidance SEATTLE, April 24, 2025 (GLOBE NEWSWIRE) -- Top Seattle periodontist and dental implant surgeon Dr. Ellie Javadi of Orchid Periodontics & Dental [...]
Sharps Technology Announces Reverse Stock Split
24/04/2025
NEW YORK, April 24, 2025 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (NASDAQ: “STSS” and “STSSW”) ("Sharps"), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class smart- [...]
Alkeus Pharmaceuticals Announces Presentations of Gildeuretinol Data During the Research in Vision and Ophthalmology (ARVO) 2025 Annual Meeting May 4-8, 2025
24/04/2025
CAMBRIDGE, Mass., April 24, 2025 (GLOBE NEWSWIRE) -- Alkeus Pharmaceuticals, Inc., a biopharmaceutical company dedicated to preserving the sight of individuals impacted by retinal diseases, today announced that results [...]
Koelis Announces Partnership with Bot Image™ at AUA 2025
24/04/2025
New AI Technology Will Improve Prostate Biopsy Accuracy and Procedure Workflow GRENOBLE, France and PRINCETON, N.J., April 24, 2025 (GLOBE NEWSWIRE) -- Koelis, SAS (“Koelis” or the “Company”, www.koelis.com ), a leader [...]

Pages